Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this case report, a 44-year-old man with alopecia areata and seborrheic dermatitis experienced hair regrowth and reduced symptoms after treatment with intralesional corticosteroids, a combination cream, and loratadine, showing improvement within four weeks.

This case report highlights a rare association between congenital triangular alopecia and vitiligo, noting that treatment with tofacitinib improved the patient's vitiligo but not the alopecia.

In this study, the use of Dravanti beeja lepa for 28 days was observed to significantly regenerate hair in patients with Indralupta (Alopecia Areata).

In this study, machine learning-based computer-aided diagnosis significantly improved accuracy in diagnosing alopecia areata compared to traditional visual methods, achieving up to 91.9% accuracy using different classifiers like CNN, SVM, and random forest models.

Early diagnosis of pseudopelade of Brocq in men is crucial to prevent permanent hair loss.

In this case report, a 60-year-old man with rheumatoid arthritis and sudden hair whitening was treated with baricitinib, showing significant hair repigmentation and regrowth in 8 months, suggesting potential for baricitinib in managing canities subita, especially when linked to alopecia areata.

This study suggests that pseudopelade may be an autonomous disease based on its distinctive clinical and histopathological features not present in other scarring alopecias.

Frontal fibrosing alopecia can affect men's beards and leads to permanent hair loss.

In this study, gelatin-coated transferosomes were developed to deliver tofacitinib specifically to hair follicles, resulting in 80% hair regrowth in alopecia areata patients with recalcitrant lesions after 12 weeks of treatment.

This review assesses the effectiveness of various alopecia areata treatments and concludes that only contact sensitizers like diphenylcyclopropenone and squaric acid dibutylester have shown efficacy in evidence-based studies, but it reports no new clinical results.

This descriptive study observed that a "moth-eaten" pattern of hair loss can occur in several skin diseases, with lichen planopilaris and discoid lupus erythematosus being among the most common conditions identified in patients from Baghdad, emphasizing its potential as a diagnostic tool for clinicians.

This review summarizes the volatile components, biological activities, and potential safety concerns of essential oils from various Curcuma species, but reports no new clinical results.

In this study, KY19382 was observed to promote hair regeneration and de novo hair follicle formation in mice by activating Wnt/β-catenin signaling, suggesting its potential as a therapeutic for alopecia.

In this study conducted at Al-Azhar University Hospital, 60% of patients with localized alopecia areata responded to treatment with autologous platelet-rich plasma, with 89% of responders showing substantial improvement, suggesting PRP as an effective treatment option for this condition.

This review discusses therapeutic principles for managing hirsutism and androgenetic alopecia during the menopausal transition and peri-/postmenopause but reports no new clinical results.

This study reports that the prevalence of male pattern baldness in Asians is higher than previously believed, with potential links to socioeconomic factors and westernized diets, though the exact cause remains unclear.

This study found that the prevalence of male pattern baldness in the Asian population in Bangkok is higher than previously thought, approaching rates seen in Caucasians.

This abstract provides author information and location affiliations for a study conducted in Bangkok, Thailand, but it does not include reported results or study details.

This study found that 2% minoxidil led to moderate to dense hair growth in 80% of Middle-Eastern men treated for 48 weeks with early androgenic alopecia.

No treatment reliably changes Alopecia Areata's course; reassurance and possibly a wig are recommended.

This paper highlights the potential efficacy of constitutional homeopathic medicine, supplemented with dietary guidance and management of associated diseases like thyroid disorders, in treating alopecia areata to expedite recovery and reduce recurrence.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Lowest effective minoxidil concentration is 1%, but 2% works better for male pattern baldness.

This article presents a computer imaging algorithm that may automate and enhance the Severity of Alopecia Tool scoring for alopecia areata through texture analysis of pediatric images.

This article reviews rosacea and rosacea-like demodicidosis, discussing historical findings, but provides no new clinical results; the authors highlight the role of Demodex in related skin conditions.

This article discusses surgical hair restoration using micrografting techniques, emphasizing its ability to produce natural-looking results without the "hair plug" appearance, and reports no new clinical findings.

This article reviews the pathogenesis, genetic basis, and recent treatment breakthroughs for androgenetic alopecia but reports no new clinical findings.

This article reviews lichen planopilaris, its presentation, and treatment challenges, and emphasizes the need for more research into its pathogenesis and therapy efficacy; it reports no new findings.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

This case report details the significant hair regrowth experienced by a 49-year-old woman with stress-related alopecia totalis after individualized homeopathic treatment, underscoring its potential effectiveness in managing both emotional trauma and hair loss.